Streetbeat News

DHC

Diversified Healthcare Trust

https://www.dhcreit.com

Industry

REIT - Healthcare Facilities

DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.

Open

2.53

Mkt cap

630M

Volume

930K

High

2.61

P/E Ratio

-1.57

52-wk high

4.24

Low

2.47

Div yield

0.02

52-wk low

1.97

Diversified Healthcare (NASDAQ:DHC) reported Q2 2024 earnings per share of $0.03, beating the analyst estimate of $0.02 by 50%. However, their sales of $371.392 million missed the estimate of $372.130 million by 0.20%. This represents a 7.27% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:55 pm

Diversified Healthcare Trust (DHC) has filed for a mixed shelf offering of up to $1.5 billion, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 8:52 pm

The Federal Reserve's indication of potential interest rate cuts in 2024 and 2025 has sparked a rally in the real estate sector, particularly benefiting stocks with high debt levels or exposure to the office industry. The Vanguard Real Estate ETF (VNQ) and the VanEck Office And Commercial Real Estate ETF (DESK) saw increases, along with significant gains for City Office REIT (CIO), Compass Inc. (COMP), Office Properties Income Trust (OPI), Anywhere Real Estate Inc. (HOUS), and Vornado Realty Trust (VNO).

Portfolio Pulse from Piero Cingari

March 21, 2024 | 9:29 pm

Diversified Healthcare (NASDAQ:DHC) reported Q4 2023 earnings of $0.03 per share, missing the consensus estimate of $0.04. However, their quarterly sales of $361.54 million exceeded the estimate of $360.99 million, marking a 7.32% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:32 pm

Numerous companies are scheduled to report their earnings on February 26, 2024, covering a wide range of industries from energy to technology. Key reports include Kosmos Energy, Krystal Biotech, Li Auto, and Domino's Pizza, among others. The diversity of sectors represented suggests a comprehensive insight into the economic and business trends affecting these markets.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 9:47 am

Diversified Healthcare (NASDAQ:DHC) announced that shareholders as of Thursday's session will be eligible for a quarterly dividend of 1 cent per share, with the ex-dividend date being Friday. The stock is expected to open 1 cent lower on Friday to reflect the dividend payout. The dividend is scheduled to be paid on February 15, 2024.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 2:45 pm

December saw a significant rally in REITs, attributed to the Federal Reserve's pause on interest rate hikes and anticipated rate cuts in 2024. Office REITs and mortgage REITs (mREITs) performed exceptionally well, with some experiencing over 20% gains. Hudson Pacific Properties (HPP) led the surge with a 53.66% return, followed by Macerich Co. (MAC), Peakstone Realty Trust (PKST), Acres Commercial Realty Corp. (ACR), and Office Properties Income Trust (OPI). Analyst upgrades and internal corporate actions, such as share repurchase programs and management changes, contributed to the positive performance of these REITs.

Portfolio Pulse from Ethan Roberts

January 03, 2024 | 4:05 pm

Diversified Healthcare Trust (DHC) has announced the appointment of Christopher Bilotto as President and CEO, effective January 1, 2024. Bilotto, currently an EVP at The RMR Group (RMR), will succeed Jennifer Francis, who is retiring from RMR and resigning from her executive positions at DHC and RMR on December 31, 2023. Francis has been with DHC's senior management since 2018 and will continue as a Managing Trustee of DHC.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 1:07 pm

Diversified Healthcare (NASDAQ:DHC) reported Q3 earnings of $0.03 per share, a 150% increase YoY. The company's quarterly sales were $356.52 million, beating the analyst consensus estimate of $353.37 million by 0.89% and marking a 10.41% increase YoY.

Portfolio Pulse from bharat@benzinga.com

November 01, 2023 | 9:12 pm

The article lists the stocks that have gained and lost the most in Tuesday's mid-day session. Some of the top gainers include InMed Pharmaceuticals, LianBio, Ascent Solar Technologies, and Falcon's Beyond Global. On the other hand, reAlpha Tech Corp, LumiraDx Limited, INVO Bioscience, and Markforged Holding Corporation were among the biggest losers.

Portfolio Pulse from Lisa Levin

October 24, 2023 | 6:12 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.